ACT34-CMI -- Adult Autologous CD34+ Cells

Clinical trial NCT00300053 · COMPLETED

Trial details

NCT number: NCT00300053
Sponsor: Lisata Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myocardial Ischemia

Start date: 2006-04-01
Primary completion: 2008-03-01
Enrollment: 321

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.